Products
Idarubicin Hydrochloride
  • Idarubicin HydrochlorideIdarubicin Hydrochloride

Idarubicin Hydrochloride

Model:57852-57-0
Idarubicin Hydrochloride is the hydrochloride salt of idarubicin, a semisynthetic anthracycline antineoplastic antibiotic and analogue of daunorubicin. The molecule of Idarubicin Hydrochloride features a tetracyclic anthraquinone chromophore with a daunosamine sugar moiety attached via glycosidic linkage.

Idarubicin Hydrochloride is a potent anthracycline antineoplastic antibiotic approved for the treatment of acute myelogenous leukemia (AML) and pediatric acute lymphocytic leukemia (ALL) . As a topoisomerase II inhibitor, Idarubicin Hydrochloride intercalates into DNA and inhibits DNA replication, ultimately interfering with RNA and protein synthesis . The high lipophilicity of Idarubicin Hydrochloride allows it to penetrate cell membranes more efficiently than other anthracycline compounds . Idarubicin Hydrochloride is rapidly metabolized to its 13-dihydro derivative (idarubicinol), which is more stable than the parent compound and contributes to its clinical activity . The compound is a substrate for CYP2D6 and CYP2C9 and induces apoptosis through enhanced expression of Fas and caspase-3/caspase-7 .

 

 Product Parameters

Parameter

Specification

Product Name

Idarubicin Hydrochloride

Synonyms

4-Demethoxydaunorubicin hydrochloride; 4-DMD; NSC 256439; Idamycin® 

CAS Number

57852-57-0

Molecular Formula

C₂₆H₂₇NO₉ · HCl

Molecular Weight

533.95 g/mol 

Appearance

Orange to red solid powder 

Melting Point

183–185 °C 

Storage Condition

2–8°C 

 

Application

Idarubicin Hydrochloride is an antimitotic and cytotoxic agent. It is used as first-line treatment for adult acute non-lymphocytic leukemia (ANLL), as well as for induction remission therapy in relapsed and refractory patients. As a second-line treatment drug, it is used for acute lymphocytic leukemia (ALL in adults and children.

 

Untoward Effect

Myelosuppression and cardiotoxicity; fatal infections; reversible alopecia; gastrointestinal reactions such as nausea, vomiting, mucositis, especially oral mucositis, esophagitis, diarrhea, fever, chills, rash; elevated liver enzymes and bilirubin; urine turns red 1 to 2 days after administration of idarubicin hydrochloride

 

Bioactivity

Idarubicin hydrochloride (4-demethoxydaunorubicin, NSC256439, 4-DMDR) is the hydrochloride salt form of idarubicin, an anthracycline antibiotic. It inhibits DNA topoisomerase II (topo II) in MCF-7 cells, with an IC50 of 3.3 ng/mL in cell-free assays. Idarubicin can induce mTOR-dependent cytotoxic autophagy.

 

Contact Us

Advancing cancer research and therapy development requires access to high-quality potent APIs and reference standards. Cosperpharm provides Idarubicin Hydrochloride with the purity and support your research demands. Reach out to our team today to discuss your specifications or request a quote.

Hot Tags: Idarubicin Hydrochloride, China, Manufacturer, Supplier, Factory
Send Inquiry
Contact Info
For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy